The main purpose of this legislation is to enhance Medicare coverage for the in-home administration of intravenous immune globulin (IVIG). This treatment is essential for patients with certain medical conditions, and the bill aims to ensure that more individuals can receive this care in the comfort of their homes. Key provisions of the legislation include expanding the list of conditions eligible for IVIG treatment under Medicare.